Abstract
Biphasic insulin aspart 30 (BIAsp 30) [NovoMix 30®] contains 30 % soluble rapid-acting insulin aspart plus 70 % intermediate-acting protaminated insulin aspart. This mixture provides prandial and basal insulin in a simple and convenient single injection. Clinical studies have shown that BIAsp 30 is an appropriate option for insulin initiation, switching, maintenance and intensification regimens. Flexible dosing (i.e. once to three times daily) and a simple dose-titration algorithm allow patients to self-titrate the dose of BIAsp 30 as required.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
